Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 147 | 3 | SARCOMA//SOFT TISSUE SARCOMA//OSTEOSARCOMA | 65246 |
| 2685 | 2 | EWINGS SARCOMA//EWING SARCOMA//DESMOPLASTIC SMALL ROUND CELL TUMOR | 3635 |
| 31397 | 1 | CD99//BATF2//CD99 ANTIGEN | 167 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | CD99 | authKW | 2912341 | 30% | 31% | 50 |
| 2 | BATF2 | authKW | 754897 | 2% | 100% | 4 |
| 3 | CD99 ANTIGEN | authKW | 424628 | 2% | 75% | 3 |
| 4 | BATF | authKW | 424622 | 4% | 38% | 6 |
| 5 | CANCER GROWTH SUPPRESSING GENE | authKW | 377448 | 1% | 100% | 2 |
| 6 | UMR 576 | address | 314534 | 3% | 33% | 5 |
| 7 | AGONIST LIGANDS | authKW | 251631 | 1% | 67% | 2 |
| 8 | CRS DEV BIOMOL THER IES | address | 234269 | 4% | 21% | 6 |
| 9 | 03 UR 08 18 | address | 188724 | 1% | 100% | 1 |
| 10 | ALTERNATIVE SPLICING ATF2 CREB1 | authKW | 188724 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 453 | 28% | 0% | 47 |
| 2 | Immunology | 345 | 23% | 0% | 38 |
| 3 | Cell Biology | 296 | 23% | 0% | 38 |
| 4 | Hematology | 164 | 10% | 0% | 17 |
| 5 | Pathology | 153 | 9% | 0% | 15 |
| 6 | Biochemistry & Molecular Biology | 133 | 26% | 0% | 44 |
| 7 | Genetics & Heredity | 88 | 11% | 0% | 18 |
| 8 | Medicine, Research & Experimental | 74 | 9% | 0% | 15 |
| 9 | Biophysics | 4 | 3% | 0% | 5 |
| 10 | Biotechnology & Applied Microbiology | 4 | 4% | 0% | 6 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | UMR 576 | 314534 | 3% | 33% | 5 |
| 2 | CRS DEV BIOMOL THER IES | 234269 | 4% | 21% | 6 |
| 3 | 03 UR 08 18 | 188724 | 1% | 100% | 1 |
| 4 | ANAT MED GENET | 188724 | 1% | 100% | 1 |
| 5 | BATTALION STUDENTS 17 | 188724 | 1% | 100% | 1 |
| 6 | DIPT PATOL SPERIMENTALE | 188724 | 1% | 100% | 1 |
| 7 | HEMATOONCOL STN | 188724 | 1% | 100% | 1 |
| 8 | HISTOL EMBYOL 2 | 188724 | 1% | 100% | 1 |
| 9 | INSERM REG LUTTE CONTRE CANC | 188724 | 1% | 100% | 1 |
| 10 | INSERM UNIT 343 | 188724 | 1% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | EXPERIMENTAL AND MOLECULAR MEDICINE | 4613 | 4% | 0% | 6 |
| 2 | MOLECULES AND CELLS | 2354 | 4% | 0% | 6 |
| 3 | IMMUNE NETWORK | 1762 | 1% | 1% | 1 |
| 4 | JOURNAL OF KOREAN MEDICAL SCIENCE | 685 | 2% | 0% | 4 |
| 5 | TRANSFUSION CLINIQUE ET BIOLOGIQUE | 662 | 1% | 0% | 2 |
| 6 | ONCOGENE | 645 | 5% | 0% | 8 |
| 7 | NAGOYA JOURNAL OF MEDICAL SCIENCE | 551 | 1% | 0% | 1 |
| 8 | IMMUNOLOGY LETTERS | 531 | 2% | 0% | 4 |
| 9 | EUROPEAN JOURNAL OF IMMUNOLOGY | 505 | 4% | 0% | 6 |
| 10 | M S-MEDECINE SCIENCES | 494 | 2% | 0% | 3 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CD99 | 2912341 | 30% | 31% | 50 | Search CD99 | Search CD99 |
| 2 | BATF2 | 754897 | 2% | 100% | 4 | Search BATF2 | Search BATF2 |
| 3 | CD99 ANTIGEN | 424628 | 2% | 75% | 3 | Search CD99+ANTIGEN | Search CD99+ANTIGEN |
| 4 | BATF | 424622 | 4% | 38% | 6 | Search BATF | Search BATF |
| 5 | CANCER GROWTH SUPPRESSING GENE | 377448 | 1% | 100% | 2 | Search CANCER+GROWTH+SUPPRESSING+GENE | Search CANCER+GROWTH+SUPPRESSING+GENE |
| 6 | AGONIST LIGANDS | 251631 | 1% | 67% | 2 | Search AGONIST+LIGANDS | Search AGONIST+LIGANDS |
| 7 | ALTERNATIVE SPLICING ATF2 CREB1 | 188724 | 1% | 100% | 1 | Search ALTERNATIVE+SPLICING+ATF2+CREB1 | Search ALTERNATIVE+SPLICING+ATF2+CREB1 |
| 8 | ANAPLASTIC CARCINOMAS | 188724 | 1% | 100% | 1 | Search ANAPLASTIC+CARCINOMAS | Search ANAPLASTIC+CARCINOMAS |
| 9 | ANTI XG ANTIBODY | 188724 | 1% | 100% | 1 | Search ANTI+XG+ANTIBODY | Search ANTI+XG+ANTIBODY |
| 10 | BATF2 SARI | 188724 | 1% | 100% | 1 | Search BATF2+SARI | Search BATF2+SARI |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |